IMUX
Price
$0.76
Change
-$0.01 (-1.30%)
Updated
Sep 5 closing price
Capitalization
75.07M
61 days until earnings call
PPBT
Price
$0.66
Change
-$0.12 (-15.38%)
Updated
Sep 5 closing price
Capitalization
2.71M
Interact to see
Advertisement

IMUX vs PPBT

Header iconIMUX vs PPBT Comparison
Open Charts IMUX vs PPBTBanner chart's image
Immunic
Price$0.76
Change-$0.01 (-1.30%)
Volume$2.05M
Capitalization75.07M
Purple Biotech
Price$0.66
Change-$0.12 (-15.38%)
Volume$3.22M
Capitalization2.71M
IMUX vs PPBT Comparison Chart in %
Loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUX vs. PPBT commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Hold and PPBT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (IMUX: $0.76 vs. PPBT: $0.66)
Brand notoriety: IMUX and PPBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 181% vs. PPBT: 254%
Market capitalization -- IMUX: $75.07M vs. PPBT: $2.71M
IMUX [@Biotechnology] is valued at $75.07M. PPBT’s [@Biotechnology] market capitalization is $2.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 1 FA rating(s) are green whilePPBT’s FA Score has 1 green FA rating(s).

  • IMUX’s FA Score: 1 green, 4 red.
  • PPBT’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMUX and PPBT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 2 TA indicator(s) are bullish while PPBT’s TA Score has 4 bullish TA indicator(s).

  • IMUX’s TA Score: 2 bullish, 5 bearish.
  • PPBT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PPBT is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а -7.20% price change this week, while PPBT (@Biotechnology) price change was -66.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

IMUX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMUX($75.1M) has a higher market cap than PPBT($2.71M). IMUX YTD gains are higher at: -23.900 vs. PPBT (-85.928). PPBT has higher annual earnings (EBITDA): -2.43M vs. IMUX (-105.1M). IMUX has more cash in the bank: 55.3M vs. PPBT (5.92M). PPBT has less debt than IMUX: PPBT (103K) vs IMUX (979K). IMUX (0) and PPBT (0) have equivalent revenues.
IMUXPPBTIMUX / PPBT
Capitalization75.1M2.71M2,775%
EBITDA-105.1M-2.43M4,322%
Gain YTD-23.900-85.92828%
P/E RatioN/A0.00-
Revenue00-
Total Cash55.3M5.92M934%
Total Debt979K103K950%
FUNDAMENTALS RATINGS
IMUX vs PPBT: Fundamental Ratings
IMUX
PPBT
OUTLOOK RATING
1..100
6550
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
8898
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a18

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PPBT's Valuation (22) in the Pharmaceuticals Major industry is in the same range as IMUX (25). This means that PPBT’s stock grew similarly to IMUX’s over the last 12 months.

PPBT's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as IMUX (100). This means that PPBT’s stock grew similarly to IMUX’s over the last 12 months.

PPBT's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as IMUX (100). This means that PPBT’s stock grew similarly to IMUX’s over the last 12 months.

IMUX's Price Growth Rating (88) in the Pharmaceuticals Major industry is in the same range as PPBT (98). This means that IMUX’s stock grew similarly to PPBT’s over the last 12 months.

IMUX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as PPBT (100). This means that IMUX’s stock grew similarly to PPBT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMUXPPBT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 15 days ago
86%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTI1.960.01
+0.51%
Drilling Tools International Corp
XOMAP26.760.11
+0.41%
XOMA Corp
AYI338.33-1.07
-0.32%
Acuity Inc
DK31.32-0.60
-1.88%
Delek US Holdings
EGY3.83-0.11
-2.79%
Vaalco Energy

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with PLRX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
-1.17%
PLRX - IMUX
36%
Loosely correlated
+14.11%
ERAS - IMUX
35%
Loosely correlated
+8.78%
NTLA - IMUX
35%
Loosely correlated
+3.79%
ORIC - IMUX
34%
Loosely correlated
+1.02%
IPSC - IMUX
34%
Loosely correlated
+5.41%
More